Frailty, Muscle Strengh, Sarcopenia
Conditions
Brief summary
Frailty is a geriatric syndrome characterized by a decrease in the function of various organs and systems that leads to a greater risk of suffering from diseases or disabilities. Frailty is usually accompanied by weight loss, loss of strength, slowing of walking speed, fatigue and poor physical activity. Frail people have more difficulty in carrying out the usual activities of daily life and a greater risk of needing help to be able to do them. The aim of this study is to evaluate the safety and effectiveness of an intervention based on the control of chronic diseases, a good use of medicines, diet, physical exercise and good social support, in the prevention . of frailty in old people who are at risk of frailty. These criteria for participating in the study are why we invite you to participate. Your participation is voluntary. Your decision to participate or not in the study will not affect the medical care you may need. Before making a decision, read this information sheet carefully and ask the person who informs you the questions you want. In the study there will be two groups, one will receive the study intervention and the other will not receive any special treatment (we call it the control group). The assignment of each individual to one group or the other will take place once you have decided to participate. This assignment will be made at random so that neither you nor your doctor can know "a priori" which group you will be in.
Detailed description
General objective: To assess the effectiveness and safety of a multimodal and multidisciplinary intervention in the prevention of sarcopenia, frailty and functional decline in pre-frail community elders aged 70 years or older. Specific objectives: 1. Evaluate the effect of the study intervention in the medium term (1 year) in terms of prevention or improvement of: 1. Muscle strength, muscle mass and sarcopenia, 2. The fragility 3. Functional capacity (and/or dependence), balance and the risk of falls 4. Nutritional status 5. The quality of life 6. The consumption of health resources in pre-frail community elders 70 years or older. 2. To evaluate the safety of the mid-term study intervention (1 year) in pre-frail community elders aged 70 years or older. Secondary objectives: 1. Assess the degree of adherence to the study intervention. 2. Evaluate the factors related to good adherence to the study intervention. 3. Describe the main characteristics of pre-frail community elders and analyze the factors associated with sarcopenia and functional impairment in the study population (cross-sectional analysis). 4. Describe the survival of the study sample and find out what the main determinants are (longitudinal analysis).
Interventions
* bimonthly personalized follow-up with the appropriate specialists (5 in a year) i * a program of group activities (6 sessions in a year) with a monitor with the aim of reinforcing adherence to the study intervention and adapting it to the circumstances and the physical, personal and social reality around each participant. The sessions will last approximately one hour and will cover: * General dietary and hydration recommendations and dietary recommendations for people at risk of malnutrition * Dietary and physical exercise recommendations in obese elderly * General physical exercise recommendations in the elderly and physical exercise recommendations in the elderly with sarcopenia * Physical exercise recommendations for the elderly at risk of falls. * Medication management and social resources for the elderly in Mataró.
Sponsors
Consorci Sanitari del Maresme
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Men or women 70 years of age or older at the time of recruitment * That they meet pre-frail phenotype criteria according to L. Fried's criteria * That they give their written informed consent to participate in the study.
Exclusion criteria
* Severe dementia (GDS\>3) * Other neurodegenerative diseases (Parkinson's disease) * Neuromuscular diseases * Serious psychiatric illness that, at the doctor's discretion, prevents good compliance with the study intervention * Active cancer * Life expectancy of less than 6 months * Institutionalized patient * Unstable ischemic heart disease, uncontrolled arrhythmias, dissecting aortic aneurysm, severe aortic stenosis, uncontrolled arterial hypertension (\>180/100mmHg), or severe heart failure. * Acute diseases or acute or poorly controlled chronic diseases * Bone fractures in the last 3 months.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Muscle Mass | baseline, 6 months and 12 months | Bioimpedance |
| Muscle strength and/or Muscle function | baseline, 6 months and 12 months | Isokinetic |
| Sarcopenia | baseline, 6 months and 12 months | EWGSOP2 description |
| Frailty | baseline, 6 months and 12 months | L Fried Criteria |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Functional Capacity 1 | baseline, 6 months and 12 months | Barthel index |
| Functional Capacity 2 | baseline, 6 months and 12 months | Lawton index |
| Functional Capacity 3 | baseline, 6 months and 12 months | Timed up and go test |
| Functional Capacity 4 | baseline, 6 months and 12 months | SPPB |
| Functional Capacity 5 | baseline, 6 months and 12 months | Unipodal test |
| Functional Capacity 6 | baseline, 6 months and 12 months | Walking speed mesured by looking time to walk 4.6 meters |
Countries
Spain
Contacts
PRINCIPAL_INVESTIGATORMateu Serra-Prat, MD PhD
Fundació Privada Salut del Consorci Sanitari del Maresme
Outcome results
None listed